Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia

Hussnain Mirza1, James Ziegler2, Sara Ford2

  • 1Department of Pediatrics, Women & Infants Hospital/The Alpert Medical School of Brown University, Providence, RI.

The Journal of Pediatrics
|September 6, 2014
PubMed

Insights

Early pulmonary hypertension (PH) in preterm infants is linked to bronchopulmonary dysplasia (BPD). This finding highlights the importance of monitoring PH in high-risk newborns to improve outcomes.

Area of Science:

  • Neonatal Medicine
  • Pediatric Cardiology
  • Respiratory Medicine

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant complication in preterm infants.
  • Pulmonary hypertension (PH) is increasingly recognized in neonates, but its early impact is not well understood.
  • Identifying early markers for BPD severity is crucial for timely intervention.

Purpose of the Study:

  • To investigate the association between early pulmonary hypertension (PH) detected in the first two weeks of life and the development of bronchopulmonary dysplasia (BPD) at 36 weeks' postmenstrual age (PMA).

Main Methods:

  • A prospective observational cohort study included preterm infants born before 28 weeks' gestation.
  • Echocardiograms were performed at 10-14 days and 36 weeks' PMA to assess for PH.
  • BPD severity was classified at 36 weeks' PMA according to the National Institutes of Health workshop definition.

Main Results:

  • Early PH was detected in 8% of enrolled infants (n=120).
  • Infants with early PH required higher fraction of inspired oxygen by day 10.
  • A significantly higher rate of moderate/severe BPD or death was observed in infants with early PH (90%) compared to those without (47%).

Conclusions:

  • Early detection of pulmonary hypertension in preterm infants is associated with an increased risk of developing moderate to severe bronchopulmonary dysplasia or death.
  • These findings underscore the clinical significance of early PH as a predictor of adverse respiratory outcomes in extremely preterm infants.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
897
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
23
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.5K
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
32
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
29
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K